Selective inhibition of human T cell cytotoxicity at levels of target recognition of initiation of lysis by monoclonal OKT3 and Leu-2A antibodies

159Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Out of a panel of seven monoclonal antibodies with affinity for human lymphoud cells, three were shown to prevent cytotoxic T cell activity, whereas none affected natural killer cell activity when applied without complement. Anti-OKT3 and anti-Leu-2a, with affinity for all T cells and the cytotoxic/suppressive subset, respectively, were both shown to inhibit T killing by their interaction with the effector cell. For anti-OKT3, the inhibition remained after free antibody was washed away. Anti-Leu-2a, in contrast, induced a rapidly reversible inhibition. Using a single cell assay, anti-OKT3 was shown to reduce the lytic ability without affecting target cell binding, whereas anti-Leu-2a prevented the effectors from binding target cells.

Cite

CITATION STYLE

APA

Landegren, U., Ramstedt, U., Axberg, I., Ullberg, M., Jondal, M., & Wigzell, H. (1982). Selective inhibition of human T cell cytotoxicity at levels of target recognition of initiation of lysis by monoclonal OKT3 and Leu-2A antibodies. Journal of Experimental Medicine, 155(5), 1579–1584. https://doi.org/10.1084/jem.155.5.1579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free